Literature DB >> 8517929

Conserved motifs in rheumatoid arthritis synovial tissue T-cell receptor beta chains.

W V Williams1, T Kieber-Emmons, Q Fang, J Von Feldt, B Wang, T Ramanujam, D B Weiner.   

Abstract

Rheumatoid arthritis is genetically linked to major histocompatibility complex (MHC) molecules (HLA-DR4 and related molecules) and characterized pathologically by high levels of HLA-DR expression and infiltration of proliferative of synovial tissue with CD4+ T lymphocytes. T-lymphocyte activation is driven by specific signaling through polymorphic alpha/beta T-cell receptors (TCRs) that are reactive with antigen-MHC complexes present at the sites of inflammation. We are interested in characterizing rheumatoid TCRs molecularly to ascertain potential binding surfaces for antigen+MHC in synovial tissue. Accordingly, we have recently investigated the TCR alpha and beta chain heterogeneity in a series of 10 rheumatoid synovia obtained at the time of joint surgery. The most frequently detected V beta families were V beta 12, 14, and 17, each of which was found in 80% of specimens. We report here the molecular cloning and sequence analysis of 20 cloned V beta segments amplified with a V beta 14 family-specific TCR primer, and six cloned V beta segments amplified with a V beta 17 family-specific TCR primer from four rheumatoid synovia. Comparison with the data base revealed that these sequences belonged to the closely related V beta 3, V beta 14, and V beta 17 families. Dominant clones were apparent in two of the individuals by the presence of identical V-D-J regions, suggesting an antigen-driven process. Amino acid sequence analysis revealed a conserved motif in the putative fourth hypervariable region or CDR4. Molecular modeling of this epitope suggests that charged side chains are available for binding to ligand structures (e.g., antigen, MHC, or superantigen). We suggest this epitope may play a role in the molecular pathogenesis of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8517929     DOI: 10.1089/dna.1993.12.425

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  8 in total

Review 1.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

2.  Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis.

Authors:  Mesut Ogrendik; Siranus Kokino; Ferda Ozdemir; Philip S Bird; Stephen Hamlet
Journal:  MedGenMed       Date:  2005-06-16

Review 3.  Role of superantigens in experimental arthritis.

Authors:  A Abdelnour; Y X Zhao; T Bremell; R Holmdahl; A Tarkowski
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Characterisation of T cell clonotypes that accumulated in multiple joints of patients with rheumatoid arthritis.

Authors:  M Kurokawa; T Kato; K Masuko-Hongo; S Ueda; T Kobata; M Okubo; T Nishimaki; T Akaza; S Yoshino; R Kasukawa; K Nishioka; K Yamamoto
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

Review 5.  T cell receptor analysis in rheumatoid arthritis: what have we learnt?

Authors:  S H Zwillich; D B Weiner; W V Williams
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 6.  T-cell antigen receptors in rheumatoid arthritis.

Authors:  L I Sakkas; P F Chen; C D Platsoucas
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Immunotherapeutic strategies targeting rheumatoid synovial T-cell receptors by DNA inoculation.

Authors:  W V Williams; Q Fang; J M Von Feldt; J D Boyer; M Luchi; B Wang; D B Weiner
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 8.  New therapeutic targets for rheumatoid arthritis.

Authors:  H J Dinant; B A Dijkmans
Journal:  Pharm World Sci       Date:  1999-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.